Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities
Net loss	$ (36,034)	$ (24,459)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	3,301	2,836
Stock-based compensation	10,416	10,863
Provision for bad debts	1,754	770
Amortization of operating lease right-of-use assets	572	301
Amortization of debt discount and issuance costs	610	559
Deferred income taxes	15	2
Revaluation of contingent royalty obligation payable to Evolus Founders	(1,763)	3,183
Other adjustments to operating activities	480	0
Changes in operating assets and liabilities:
Inventories	(4,291)	3,749
Accounts receivable	(1,781)	(13,390)
Prepaid expenses	(1,443)	193
Accounts payable	3,945	(246)
Accrued expenses	(12,835)	(1,023)
Operating lease liabilities	(256)	(353)
Other operating assets	(3,113)	(70)
Net cash used in operating activities	(40,423)	(17,085)
Cash flows from investing activities
Purchases of property and equipment	(1,007)	(721)
Additions to capitalized software	(3,121)	(1,330)
Net cash used in investing activities	(4,128)	(2,051)
Cash flows from financing activities
Payment of contingent royalty obligation to Evolus Founders	(4,416)	(3,607)
Proceeds from issuance and modification of debt instruments	25,000	0
Payments for debt modification fees and costs	(2,610)	0
Proceeds from follow-on offering	0	51,211
Payments for offering costs	0	(248)
Issuance of common stock in connection with incentive equity plan	1,065	2,787
Payment of financing lease obligation	(7)	0
Net cash provided by financing activities	19,032	50,143
Effect of exchange rates on cash and cash equivalents	305	(174)
Net increase (decrease) in cash and cash equivalents	(25,214)	30,833
Cash and cash equivalents, beginning of period	86,952	62,838
Cash and cash equivalents, end of period	61,738	93,671
Supplemental disclosure of cash flow information
Cash paid for interest	7,786	8,838
Cash paid for income taxes	$ 317	$ 164